Xenon Short Arc Lamp Market Analysis by Size, Share, Growth, Trends up to 2025
  Author: Admin

Latest update on Xenon Short Arc Lamp Market Analysis report published with an extensive market research, Xenon Short Arc Lamp market growth analysis and Projection by – 2025. this report is highly predictive as it holds the over all mark...

Read More >>
Li-ion Battery Management ICs Market Research, Recent Trends and Growth Forecast 2025
  Author: Admin

Latest update on Li-ion Battery Management ICs Market Analysis report published with an extensive market research, Li-ion Battery Management ICs market growth analysis and Projection by – 2025. this report is highly predictive as it holds...

Read More >>
Frequency Converter Market Size Growth Forecast 2020 to 2025
  Author: Admin

A Research study on Frequency Converter Market analyzes and offers ideas of exhaustive research on ancient and recent Frequency Converter market size. Along with the estimated future possibilities of the market and emerging trends in the Freque...

Read More >>
Wireless POS System Market Demand, Recent Trends and Developments Analysis 2025
  Author: Admin

The Wireless POS System Market report upholds the future market predictions related to Wireless POS System market size, revenue, production, Consumption, gross margin and other substantial factors. It also examines the role of the prominent Wir...

Read More >>
Ultra-Small Case Size Passive Electronic Component Market Size Growth Forecast 2020 to 2025
  Author: Admin

A Research study on Ultra-Small Case Size Passive Electronic Component Market analyzes and offers ideas of exhaustive research on ancient and recent Ultra-Small Case Size Passive Electronic Component market size. Along with the estimated future...

Read More >>
Hot Carrier Diode Market Share Analysis and Research Report by 2025
  Author: Admin

The Hot Carrier Diode Market report upholds the future market predictions related to Hot Carrier Diode market size, revenue, production, Consumption, gross margin and other substantial factors. It also examines the role of the prominent Hot...

Read More >>
Stadium LED Display Market Research Report, Growth Forecast 2025
  Author: Admin

Latest update on Stadium LED Display Market Analysis report published with an extensive market research, Stadium LED Display market growth analysis and Projection by – 2025. this report is highly predictive as it holds the over all ma...

Read More >>
2019-nCoV Detection Server Market Research Report, Growth Forecast 2025
  Author: Admin

Latest update on 2019-nCoV Detection Server Market Analysis report published with an extensive market research, 2019-nCoV Detection Server market growth analysis and Projection by – 2025. this report is highly predictive as it holds the over al...

Read More >>
Ultrasound Probe Disinfection System Market Research, Recent Trends and Growth Forecast 2025
  Author: Admin

A Research study on Ultrasound Probe Disinfection System Market analyzes and offers ideas of exhaustive research on ancient and recent Ultrasound Probe Disinfection System market size. Along with the estimated future possibilities of the market and e...

Read More >>
Partial Ossicular Replacement Prostheses Market Share Analysis and Research Report by 2025
  Author: Admin

A Research study on Partial Ossicular Replacement Prostheses Market analyzes and offers ideas of exhaustive research on ancient and recent Partial Ossicular Replacement Prostheses market size. Along with the estimated future possibilities of the ...

Read More >>
Pharmaceutical Containers Market Forecast 2020-2025, Latest Trends and Opportunities
  Author: Admin

A Research study on Pharmaceutical Containers Market analyzes and offers ideas of exhaustive research on ancient and recent Pharmaceutical Containers market size. Along with the estimated future possibilities of the market and emerging trends in the ...

Read More >>
COVID-19: Oxford’s vaccine trials to continue after a subject’s death
  Author: Nikita Chaurasia

The deceased volunteer was reportedly subjected to a placebo and not the actual COVID-19 vaccine. The Brazilian government plans on purchasing the ...

Read More >>
Johnson & Johnson halts COVID-19 vaccine study as participant falls ill
  Author: Nikita Chaurasia

  Johnson & Johnson had initially planned to enroll over 60,000 participants for its phase 3 clinical trials. Experts claim that c...

Read More >>
Diabetes drug metformin recalled over high levels of cancer contaminant
  Author: Nikita Chaurasia

Metformin hydrochloride, a widely used diabetes drug, has reportedly been recalled after manufacturers detected high levels of cancer-causing contaminant in it. According to reliable sources, the latest recall by the U...

Read More >>
Eli Lilly requests for EUA approval from FDA for COVID-19 antibody
  Author: Nikita Chaurasia

Eli Lilly and Company, the American pharmaceutical giant, has reportedly applied for emergency use authorization (EUA) for its potential COVID-19 antibody from the Food & Drug Administration (FDA). Sources with kno...

Read More >>
Bristol Myers Squibb to acquire MyoKardia for access to CVD treatment
  Author: Nikita Chaurasia

  BMS intends to acquire the biotech firm for USD 13 billion. The potential drug of MyoKardia will be sent for FDA approval during Q1...

Read More >>
UnitedHealthcare to expand its Medicare Advantage footprint by 50%
  Author: Nikita Chaurasia

  The company has registered around 6.5 million enrollments in its programs. UnitedHealthcare plans to include additional 3.2 million ...

Read More >>
New research claims sufficiency of vitamin D reduces COVID-19 severity
  Author: Nikita Chaurasia

According to a recent study, COVID-19 patients having sufficient levels of vitamin D, with at least 30 ng/mL of 25-hydroxyvitamin D in their blood, are less likely to witness severe clinical outcomes and deaths. ...

Read More >>
Breast cancer: New treatment claims to reduce recurrence risk by 25%
  Author: Nikita Chaurasia

  The research comprised of patients with increased cellular proliferation and larger tumor size monarchE trials were funded by Eli Li...

Read More >>
Todos, NCL Pharma adds NLC-001 dietary supplement to its joint venture
  Author: Nikita Chaurasia

Todos Medical Ltd., an Israeli in-vitro diagnostic company based, recently announced that NLC Pharma, Inc., its joint venture partner, has added the NLC-001 dietary supplement to their COVID-19 focused-partnership. Thi...

Read More >>
Oxford’s recovery trial to evaluate REGN-COV2 for COVID-19 treatment
  Author: Nikita Chaurasia

According to credible sources, the University of Oxford has announced that it will be initiating the Recovery Trial for testing REGN-COV2, an experimental drug developed for the treatment of the COVID-19 virus. ...

Read More >>
Korean scientists claim energy source of cancer cells are fatty acids
  Author: Nikita Chaurasia

Korean researchers have reportedly discovered that fatty acids are the primary energy source for cancer cells. The study, which was published in the latest issue of the International Journal (Cancer), was confirmed by ...

Read More >>
Duly approved COVID-19 vaccine may take time claim Pharma giants
  Author: Nikita Chaurasia

According to credible sources, nine pharmaceutical organizations including Merck & Co Inc. and Pfizer Inc. have recently issued a joint pledge to not put forward a COVID-19 vaccine until it has been vetted for effi...

Read More >>
Omron Healthcare India profits to surpass USD 21.93 million in FY21
  Author: Nikita Chaurasia

  Omron aims to record 27% spike in revenues by FY21 The revenue growth is attributed to rising cognizance regarding home monitoring s...

Read More >>
Post-COVID-19 inflammatory syndrome puts children’s hearts at risk
  Author: Nikita Chaurasia

New study published in EClinicalMedicine, a journal of The Lancet, shows link between multisystem inflammatory syndrome in children (MIS-C) and COVID-19. Senior author of the medica...

Read More >>
Novan announces first clinical testing for SB206 on molluscum patients
  Author: Nikita Chaurasia

Novan Inc., U.S.-based clinical stage pharmaceutical company, has reportedly announced first patient enrollment in its B-SIMPLE4 pivotal Phase 3 clinical study of SB206, an antiviral gel used for treating molluscum con...

Read More >>
Finally, WHO has some good news for 213 covid-19 impacted countries
  Author: Nikita Chaurasia

The World Health Organization on Wednesday reported that widely available and low-cost corticosteroids can aid covid-19 positive patients suffering from serious symptoms. The body also warned against the use of cortico...

Read More >>
New research claims honeybee venom can inhibit growth of cancer cells
  Author: Nikita Chaurasia

According to a recent study published in NPJ Precision Oncology journal by Harry Perkins Institute of Medical Research, honeybee venom is capable of rapidly destroying HER2-enriched breast cancer cells and triple-negat...

Read More >>
AstraZeneca to present results of Farxiga’s DAPA-CKD trial at ESC 2020
  Author: Mateen Dalal

According to reliable sources, British-Swedish multinational pharmaceutical company AstraZeneca plc will present the much awaited results of the Phase III DAPA-CKD trial of Farxiga in CKD (chronic kidney disease) at ES...

Read More >>
FDA grants Emergency Use Authorization to Abbott’s COVID-19 antigen
  Author: Mateen Dalal

Abbott Laboratories, a U.S.-based medical devices and healthcare firm, has reportedly received the Emergency Use Authorization (EUA) from the U.S. FDA (Food and Drug Administration) for the detecting COVID-19 virus wit...

Read More >>
FDA grants Fast Track Designation to Polaryx Therapeutics’ PLX-200
  Author: Nikita Chaurasia

Polaryx Therapeutics Inc., a biotechnology firm which develops small molecule therapeutics, has reportedly been granted approval by the U.S. FDA (Food & Drug Administration) of Fast Track Designation for analyzing ...

Read More >>
Salmonella outbreak forces HelloFresh to recall meal kits with onions
  Author: Nikita Chaurasia

HelloFresh, an international meal-kit provider based in Berlin, Germany, has reportedly issued a recall of the products in view of the salmonella infection that has affected 900 Americans, with over 100 hospitalized....

Read More >>
One in three UK firms to cut jobs by third quarter of 2020, poll finds
  Author: Nikita Chaurasia

According to a recent study regarding the economic impact of COVID-19, one in three employers in the United Kingdom are predicted to cut jobs by the third quarter of 2020. Sources close to the matter stated that the su...

Read More >>
Novavax’s COVID-19 vaccine shows promising results in first trial
  Author: Nikita Chaurasia

America-based vaccine development company Novavax Inc. has reportedly announced a potential COVID-19 vaccine which showcased a promising immune response in the early stage of its clinical trial. The trials for phase on...

Read More >>
NHS requests urgent donations of blood plasma from COVID-19 survivors
  Author: Mateen Dalal

According to reliable sources, United Kingdom National Health Service (NHS) has filed an appeal to the individuals recuperated from novel coronavirus to donate blood plasma. The organization apparently intends to treat...

Read More >>
Coronavirus Breaking: New Covid-19 test gives results in just 36 min
  Author: Nikita Chaurasia

The Nanyang Technological University (NTC), Singapore, on Monday, announced that Lee Kong Chain School of Medicine, has demonstrated an astonishing way to accelerate the speed, handling time, and cost of Covid-19 lab t...

Read More >>
OSE Immunotherapeutics receives $228,000 to develop COVID-19 vaccine
  Author: Mateen Dalal

The novel coronavirus outbreak has turned out to be one of the worst disasters the world has witnessed in recent times. At times like this, pharmaceutical companies worldwide have been putting their best foot forward t...

Read More >>
Biolidics lands 5-year licensing deal to develop COVID-19 test kits
  Author: Nikita Chaurasia

Biolidics, a precision medicine medical technology company, headquartered in Singapore, on July 9 inked an agreement with the commercialization arm of the Agency for Science, Technology and Research (A*Star), Accelerat...

Read More >>
Glenmark cuts prices of its COVID-19 drug FabiFlu to USD 1 per pill
  Author: Nikita Chaurasia

As per credible sources, Mumbai-based Glenmark Pharmaceuticals Ltd. recently revealed that it has slashed the price of its coronavirus drug FabiFlu by 27%, from USD 1.37 to USD 1 per pill. ...

Read More >>
40% of COVID-19 patients are asymptomatic, a new CDC report claims
  Author: Mateen Dalal

The ongoing coronavirus pandemic has wreaked havoc worldwide. Dismissed as a slight by the world initially, the virus shocked the scientific and medical communities alike, with the rapid rate of spreading. Very little ...

Read More >>
High likeliness of COVID-19 damaging the brain, claim scientists
  Author: Mateen Dalal

The advent of COVID-19 has turned out to be one of worst disasters the world has seen in recent times. In an attempt to thwart its spread, myriad efforts are being undertaken, along the likes of social distancing, nati...

Read More >>
Scientists say COVID-19 is airborne, ask WHO to revise recommendations
  Author: Nikita Chaurasia

Numerous scientists across the globe have reportedly sent an open letter to WHO (World Health Organization) seeking the health agency to revise recommendations regarding the novel coronavirus. ...

Read More >>
FDA approves ‘Rukobia’ for HIV patients with limited treatment options
  Author: Mateen Dalal

The use of antiretroviral therapies (ART) to battle HIV (Human Immunodeficiency Virus) is one of the great achievements of modern medicine. The ART medications can transform HIV from a fatal infection into a more manag...

Read More >>
HSA: Banned substances found in two weight loss products online
  Author: Nikita Chaurasia

HSA (The Health Sciences Authority of Singapore) has reportedly issued an alert regarding two weight loss products found online which comprise of banned substances and can be harmful to the human health. The agency has...

Read More >>
First batch of TraceTogether tokens released among vulnerable seniors
  Author: Nikita Chaurasia

Reportedly, the first batch of TraceTogether tokens was distributed yesterday among vulnerable seniors who live by their own and do not utilize any digital devices. The functioning of the tokens is like that of the sma...

Read More >>
Sanofi and Translate Bio to jointly produce mRNA Covid-19 vaccine
  Author: Nikita Chaurasia

French multinational pharmaceutical company Sanofi S.A. is reportedly expanding its collaboration with Translate Bio, a U.S-based mRNA therapeutics company to develop a wide range of messenger ribonucleic acid (mRNA) v...

Read More >>
EMA validates use of BAVENCIO for treating Urothelial Carcinoma
  Author: Nikita Chaurasia

German multinational pharmaceutical, chemical, and life sciences company, Merck KGaA, headquartered in Darmstadt, recently declared that the European Medicines Agency (EMA) has approved the review process for the Type II variation application for ...

Read More >>
Spike in COVID cases: Long queues seen at testing clinics in Melbourne
  Author: Nikita Chaurasia

Reportedly, long traffic queues were spotted snaking out of car parks at Northland and Southland shopping centers as people flocked at testing clinics, after the recent spike in COVID-19 cases in Victoria, Melbourne....

Read More >>
Low-dose steroid dexamethasone to be used for treating COVID-19 in U.K.
  Author: Nikita Chaurasia

As reported by credible sources, in a recent development the U.K. government has permitted the state-funded NHS (National Health Service) to use an anti-inflammatory steroid called “dexamethasone” for treat...

Read More >>
Under Armour launches special face masks designed for workout
  Author: Mateen Dalal

In a bid to make working out more convenient during the ongoing pandemic, Under Armour, Inc., has reportedly launched the first-of-kind facial mask designed for the workout which brings hope to runners, cyclists, and a...

Read More >>
UNC School of Medicine announces new kind of test for COVID-19
  Author: Mateen Dalal

With the number of people testing positive for COVID-19 increasing to over 7.5 million, the need for extensively applicable surveillance testing for better understanding of infection rates, particularly the number of i...

Read More >>
J&J to begin human trial of COVID-19 vaccine in U.S. and Belgium
  Author: Mateen Dalal

Johnson & Johnson, a multinational medical device & pharmaceuticals company, has recently announced its plan to commence the human trial of a potential COVID-19 vaccine by the 2nd half of July 2020. The drug ma...

Read More >>
New Wave Holdings Corp. funds Delos Psyche to back LSD research
  Author: Mateen Dalal

New Wave Holdings Corp., a Canadian company that focuses on entertainment and esports facilities, has recently announced that it would support the Delos Psyche Research Group in its research on determining the impact o...

Read More >>
India approves the emergency use of remdesivir for COVID-19 treatment
  Author: Mateen Dalal

India’s Drug Controller General, VG Somani, has reportedly authorized the use of remdesivir for the treatment of coronavirus patients. Remdesivir is a novel drug developed by renowned pharmaceutical firm Gilead S...

Read More >>
Scientists devise method to decrease coronavirus count in plasma, blood
  Author: Mateen Dalal

Ever since COVID-19 has ravaged the globe, claiming more than 3 lakh lives, various research organizations and scientists the world over, have been striving to introduce a vaccine or a medication or a potential method ...

Read More >>
Netsmart introduces unique mobile screening solution for COVID-19
  Author: Mateen Dalal

In the face of the ongoing pandemic spread worldwide, that has disrupted businesses and turned normal lives upside down, companies have been striving to bring about innovative solutions that can ensure people to remain adequately and correctly inf...

Read More >>
First suspected cases of MIS-C under examination in South Korea
  Author: Mateen Dalal

Health authorities in South Korea have lately announced the ongoing medical examination of two children cited as suspected cases of a life-threatening syndrome associated with coronavirus. The two children are apparent...

Read More >>
Teva presents AJOVY’s new data on migraine impact in European adults
  Author: Mateen Dalal

The analysis examines impact of migraine in areas of Spain, France, and the United Kingdom. Migraine has been one of the prominent neurological condit...

Read More >>
Chinese university conducts trials to launch new Covid-19 drug
  Author: Mateen Dalal

Scientists at Peking University in China have successfully conducted tests for a new drug which they claim could help in containing the coronavirus pandemic. Since its outbreak in China, the disease continues to be a m...

Read More >>
Moderna’s Phase 1 vaccine trial produces antibodies against SARS-CoV-2
  Author: Mateen Dalal

Moderna, Inc., an American biotechnology company, recently announced that its coronavirus vaccine candidate has produced protective antibodies among a group of healthy volunteers. E...

Read More >>
Gilead inks non-exclusive licensing pacts with 5 generic drug-makers
  Author: Mateen Dalal

Gilead Sciences, an American biopharmaceutical company, has recently inked non-exclusive licensing pacts with 5 India- and Pakistan-based generic drug-makers. These licensing agreements have been made to increase the s...

Read More >>
South Korea delays school reopening due to new COVID-19 cluster
  Author: Mateen Dalal

South Korea has delayed the process of reopening schools by a week due to the fears of possible 2nd wave of COVID-19 infections. The latest coronavirus cases stem from a new cluster traced to 5 clubs and bars in Itaewon. The number of infe...

Read More >>
Enlivex commences phase II study of Allocetra in COVID-19 patients
  Author: Mateen Dalal

The world has joined forces to develop a vaccine for COVID-19 and companies across the globe are scrambling for the first breakthrough. Since the coronavirus spreads easily and is already weakening the healthcare syste...

Read More >>
Gilead in talks with Indian drug producers to offer patented remdesivir
  Author: Mateen Dalal

Gilead Sciences, an American biopharmaceutical company, has recently engaged in talks with some leading chemical & pharmaceutical companies in countries including India. The discussion has been held on remdesivir, ...

Read More >>
HSA issues stern warning over falsely advertised health products
  Author: Mateen Dalal

Singapore’s health statutory board, the Health Sciences Authority (HSA) has recently deleted over 1,700 listings of products from local websites that were falsely making COVID-19-related claims. These products in...

Read More >>
University Hospital Southampton tests Synairgen’s new COVID-19 drug
  Author: Mateen Dalal

UK scientists have developed a new drug for treating coronavirus patients that will be put to trial in the University Hospital at Southampton. UK-based biotech firm, Synairgen has developed this drug which uses the pro...

Read More >>
Gilead Sciences shows positive results for remdesivir as COVID-19 drug
  Author: Mateen Dalal

Gilead Sciences, the maker of remdesivir, has recently revealed positive results from trials for the drug. The trials were conducted to evaluate the potential of the medication as a treatment for the novel coronavirus....

Read More >>
Victoria set for 100,000 COVID-19 tests prior to ease of restrictions
  Author: Mateen Dalal

Daniel Andrews, the Premier of Victoria, has reportedly stated that 100,000 COVID-19 tests will be conducted in 2 weeks ahead of easing of stage 3 restrictions. Mr. Andrews has adde...

Read More >>
Practitioners doubt the efficacy of hydroxychloroquine for COVID-19
  Author: Mateen Dalal

As the debate on hydroxychloroquine’s effectiveness over COVID-19 intensifies, a significant number of physicians across the globe still presume that patients should consume the drug to treat the symptoms of COVI...

Read More >>
Ramsay Health Care lauds Australia’s plan to resume elective surgeries
  Author: Mateen Dalal

Ramsay Health Care, a leading provider of healthcare services in Australia, Malaysia, Indonesia and the U.K, has reportedly welcomed a plan proposed by Australia to resume elective surgeries, considering it as a decent...

Read More >>
Novartis receives FDA nod for malaria drug trial on COVID-19 patients
  Author: Mateen Dalal

Novartis has received approval from the U.S. Food and Drug Administration for clinical trials to study the efficacy of hydroxychloroquine, which is essentially a drug for malaria, for the treatment of hospitalized pati...

Read More >>
Oxford University to commence human trials on a COVID-19 vaccine
  Author: Nikita Chaurasia

The university’s vaccine programme has hired around 510 people to take part in the first trial. As the deadly coronavirus have paved its way to almost every c...

Read More >>
UK regulator gives green light to Penlon’s ESO2 medical ventilator
  Author: Mateen Dalal

As the COVID-19 pandemic has significantly increased the demand for ventilators, leading manufacturers worldwide have responded quickly by surging production. However, ventilator manufacturers are still waiting to get ...

Read More >>
GSK & Sanofi join forces to discover an effective vaccine for COVID-19
  Author: Nikita Chaurasia

Amidst growing concerns over the coronavirus, numerous medical institutes and pharmaceutical companies are diligently working on developing an effective vaccine to tackle this deadly virus. France’s Sanofi S.A. a...

Read More >>
Mayo Clinic & the University of Minnesota offer antibody testing
  Author: Mateen Dalal

In a bid to curb the spread of coronavirus, several medical institutes and researchers are conducting striding initiatives like community-wide testing and drug development. Recently, the University of Minnesota and May...

Read More >>
Kentucky & Kroger team up to open drive-thru COVID-19 testing centers
  Author: Mateen Dalal

The Governor of Kentucky, Andy Beshear has reportedly stated that the state of Kentucky is teaming up with renowned retail chain company, Kroger, to open free drive-thru coronavirus testing centers throughout the state...

Read More >>
AIVITA declares updates for AV-GMB-1 clinical trial in GBM patients
  Author: Mateen Dalal

AIVITA Biomedical, Inc., a biotech firm developing innovative cell therapies, has recently announced updates to the survival data after the year-end analysis of the ongoing AV-GBM-1 Phase 2 clinical trial in newly diag...

Read More >>
Walgreens will provide drive-thru testing for COVID-19 in 7 US states
  Author: Mateen Dalal

Walgreens, a leading drug store chain in the United States recently announced plans to open 15 drive-thru facilities for coronavirus COVID-19 testing in seven states. With mounting ...

Read More >>
Australian researchers discover anti-parasite drug that kills COVID-19
  Author: Nikita Chaurasia

Researchers at Monash University, Melbourne, have reportedly announced that they discovered that an anti-parasite medicine can kill the novel strain of the coronavirus (SARS-CoV-2) that has currently brought the world ...

Read More >>
Gilead to donate 1.5M doses of remdesivir to treat COVID-19 patients
  Author: Mateen Dalal

Gilead Sciences, Inc., an American biotechnology company, has recently announced its plan to donate 1.5 million doses of the investigational drug, remdesivir. These 1.5 million doses will be used for over 140,000 treat...

Read More >>
Home Depot to reserve masks for frontline healthcare professionals
  Author: Mateen Dalal

As COVID-19 cases continue to soar in America, medical professionals on the front lines are facing a shortage of masks and other protective equipment. To cope up with increasing demand, The Home Depot Inc., one of the ...

Read More >>
Analytics 4 Life reveals new data backing novel method to predict LVEDP
  Author: Nikita Chaurasia

Analytics 4 Life, one the leading digital health company committed to improving existing diagnostic pathways, has reportedly presented data on its heart failure research at the ACC’s (American College of Cardiolo...

Read More >>
1CellBio to provide early access to new targeted cell sequencing
  Author: Mateen Dalal

The U.S.-based biotechnology company, 1CellBio Inc. has recently revealed early access program for its latest droplet-based targeted cell sequencing and selection abilities. Reportedly, this latest approach aligns with...

Read More >>
Esperion presents pooled analyses of NEXLETOL & NEXLIZET at ACC.20/WCC
  Author: Nikita Chaurasia

Esperion Therapeutics, a US-based public pharmaceutical company, reportedly unveiled that two pooled data analyses from its 4 Phase 3 clinical studies of NEXLETOL and outcomes from Phase 2 trial of NEXLIZET were showca...

Read More >>
Novartis releases Phase 3 trial data that assesses hyperlipidemia drug
  Author: Mateen Dalal

Novartis, a renowned biopharmaceutical company, has reportedly released the outcomes of a prespecified analysis of pooled information from three Phase 3 trials that evaluate the efficacy and safety of inclisiran, the c...

Read More >>
miDiagnostics secures €14M to commercialize rapid clinical testing
  Author: Mateen Dalal

Leuven-based biotech firm miDiagnostics has recently concluded a €14 million investment round. The funding round was led by leading life science and technology investors, including Dr. Ir. Urbain Vandeurzen and Dr...

Read More >>
ATUM to offer Protein Synthesis Platform to COVID-19 test tool developers
  Author: Mateen Dalal

As the coronavirus pandemic reaches community level, prominent companies have come forward to aid medical researchers in accelerating their drug development process. ATUM, an American biotechnology firm, recently made ...

Read More >>
Researchers in UK develop a new, low-cost test kit for COVID-19
  Author: Nikita Chaurasia

Amidst growing concerns over the coronavirus pandemic, several health researchers have started to innovate new medical apparatus and drugs to help combat this novel virus. Recently, a bunch of researchers from the Univ...

Read More >>
InMed files CTA to start second Phase 1 INM-755 clinical trial
  Author: Nikita Chaurasia

InMed Pharmaceuticals Inc., a leading biopharmaceutical company which develops medications targeting diseases with unmet needs, has reportedly announced the filing of CTA (Clinical Trial Application) in the Netherlands...

Read More >>
Vapotherm reveals business update following COVID-19 pandemic
  Author: Nikita Chaurasia

Vapotherm, Inc., a global medical technology firm developing and manufacturing proprietary Hi-VNI Technology products, has reportedly announced an update on its business in response to the COVID-19 pandemic. ...

Read More >>